Observational studyPregnancy hypertension2025
Evaluation of a remote blood pressure monitoring program during pregnancy: utilization and implementation outcomes.
Observational study in Pregnancy hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prenatal remote blood pressure monitoring: Impacts on blood pressure measurement and health outcomes.Pregnancy (Hoboken, N.J.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesTo identify factors associated with enrollment, retention, and patient engagement in the antenatal remote blood pressure (BP) monitoring program, Connected MOM, and to evaluate program implementation by race and residence. STUDY
designRetrospective cohort.
main outcome measuresImplementation outcomes (adoption, reach, implementation, sustainability, acceptability) and rates of patient enrollment, retention and engagement.
results34,387 Connected MOM-eligible pregnancy episodes (29,897 unique patients) were identified between November 1, 2016 and October 1, 2023. Of those, 8,471 pregnancies (24.6 %) had no offer made by the provider; 1,371 pregnancies (4.0 %) declined participation; 7,509 pregnancies (21.8 %) had an order placed but did not sign the consent form; 6,471 pregnancies (18.8 %) consented and onboarded, but did not submit a remote BP reading required to become enrolled; and 10,565 pregnancies (30.7 %) enrolled. Of those who were offered participation, approximately 40 % of eligible patients enrolled in the program; however, White (44.3 %) and urban patients (40.0 %) were more likely to enroll than Black (35.3 %) and rural patients (24.5 %) (p < 0.0001). Program attrition was very low (1.3 %) and patients averaged at least one BP reading per week about 50 % of the weeks enrolled. Lower patient engagement was associated with Black race (p < 0.0001), rural residence (p = 0.030), and having a public insurance payer (p < 0.0001). Highly engaged patients were more likely to have highly engaged providers (RR = 1.06, 95 % CI, 1.02-1.11).
conclusionIdentifying and addressing barriers at each step along the enrollment pathway is required for equitable implementation and improvement in maternal outcomes. Provider engagement in the program should be encouraged to improve patient engagement once enrolled.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.